Trial · NCT02179294
A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour
NCT02179294, Phase 4, Completed, University of Birmingham
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour. Trials, record NCT02179294. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02179294
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour
- NCT number
- NCT02179294
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 401 participants, actual
- Lead sponsor
- University of Birmingham
- Conditions
- Pain Relief in Labour
- Interventions
- Pethidine, Remifentanil
- First posted
- 2014-07-01
- Last updated
- 2018-10-15
- Other registries' IDs
- eudract:2012-005257-22
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The proportion of women who receive epidural analgesia for pain relief in labour, in each group, after randomisation. | At labour | The proportion of women who receive epidural analgesia for pain relief in labour, in each group, after randomization. |
| Secondary | • The effectiveness of pain relief provided by each technique, quantified by Visual Analogue Scale | Post natally - Average of 2-3days after delivery | • The effectiveness of pain relief provided by each technique, quantified by Visual Analogue Scale |
| Secondary | The incidence of maternal side effects | Post Natally - Average of 2-3days after delivery | The incidence of maternal side effects including * Excessive sedation score * Oxygen Saturation \<94% whilst breathing room air * Nausea requiring anti-emetic administration * Requirement and indication for supplemental oxygen * Respiratory Depression (Respiratory rate \< 8 breaths/minute) |
| Secondary | Delivery mode (Spontaneous, Instrumental Vaginal, Caesarean Section) | Post Natally - Average of 2-3days after delivery | Delivery mode (Spontaneous, Instrumental Vaginal, Caesarean Section) |
| Secondary | Incidence of foetal distress requiring delivery | Post Natally - Average of 2-3days after delivery | Incidence of foetal distress requiring delivery |
| Secondary | Neonatal status at delivery | Post Natally - Average of 2-3days after delivery | Neonatal status at delivery: * Apgar score at 5 minutes * Incidence of foetal acidosis determined by umbilical cord gas analysis * Requirement for neonatal resuscitation * Incidence of and indication for admission to neonatal care |
| Secondary | Rate of initiation of breast feeding within the first hour of birth | Post Natally - 1 hour after delivery | Rate of initiation of breast feeding within the first hour of birth |
| Secondary | Maternal satisfaction with childbirth experience determined by postpartum questionnaire prior to discharge from the delivery ward | Post Natally - Average of 2-3days after delivery | Maternal satisfaction with childbirth experience determined by postpartum questionnaire prior to discharge from the delivery ward |
| Secondary | Maternal birth experience determined by qualitative telephone interview up to six weeks postpartum | Up to 6 weeks post-partum | Explore and compare women's birth experiences up to six weeks postpartum via qualitative telephone interview (Post-Natal sub-study) |
| Secondary | Maternal perceptions of pain relief determined by qualitative telephone interview up to six weeks postpartum | Up to 6 weeks post-partum | Explore and compare women's perceptions of pain relief up to six weeks postpartum via qualitative telephone interview (Post-Natal sub-study) |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02179294
GET https://conductscience.org/api/trials/v1/NCT02179294/registered